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Mycobacterium bovis caused 3% of human tubercu-
losis cases in southwest Ireland during 1998–2006. Of 11 
M. bovis strains genotyped, 9 belonged to common animal 
spoligotypes. Seven strains were from sputum and poten-
tial sources of human-centered disease transmission. Ten-
locus variable-number tandem repeat typing gave unique 
strain profi les and would detect disease outbreaks. 
Bovine tuberculosis occurs worldwide (1–3). It is caused by Mycobacterium bovis, a cattle-adapted member of 
the M. tuberculosis complex. M. bovis has the broadest host 
range of pathogenic mycobacteria, infecting domestic and 
wild mammals, and is classifi ed as a Hazard Group 3 in-
fectious agent (1). Human infection follows ingestion of 
unpasteurized milk or inhalation of droplet nuclei (1). In 
many countries, the risk for M. bovis infection in humans 
has been reduced by a test-and-slaughter program in which 
infected cattle are identifi ed and culled. This program has 
eradicated M. bovis cattle infection from 11 states of the 
European Union (3). However, the Republic of Ireland and 
its neighbor the United Kingdom have failed to eradicate 
bovine tuberculosis (1,4). In the 1980s, 4%–6% of all cases 
of laboratory-confi rmed tuberculosis in southwest Ireland 
were caused by M. bovis (5). Our study results suggest that 
this remains a problem in Ireland. 
Molecular typing systems for pathogenic mycobacte-
ria are important for epidemiologic control because they 
enable case-linking and outbreak tracing (6). We report 
a molecular epidemiology study that used spoligotyping, 
mycobacterial interspersed repetitive units–variable-num-
ber tandem repeat (MIRU-VNTR) typing, and region of 
difference (RD) typing of M. bovis strains isolated from 
human residents of Ireland. 
The Study
During 1998–2006, the microbiology laboratory at 
Cork University Hospital obtained M. tuberculosis com-
plex isolates from 501 patients (equivalent to 68.5% of no-
tifi ed cases) residing in southwest Ireland (counties Cork 
and Kerry); 15 were M. bovis isolates (3%). Eleven of 
these M. bovis strains were available for testing. Seven ad-
ditional isolates obtained over this period (from inoculation 
abscesses) were identifi ed as M. bovis BCG and not ana-
lyzed. Strains were identifi ed as M. tuberculosis complex 
by using Accuprobe (Gene-Probe, San Diego, CA, USA) 
and as potential M. bovis strains by pyruvate dependence. 
Defi nitive identifi cation was performed at the Mycobacte-
rial Reference Unit in London and was based on absence of 
niacin production and nitrate reductase activity, thiophen-
2-carboxylic acid hydrazide negativity, and pyrazinamide 
resistance (1). DNA extraction was performed as described 
(2). DNA controls were M. tuberculosis H37Rv and M. 
bovis AF2122/97. A 6-locus panel VNTR (exact tandem 
repeat [ETR]-A to ETR-F) (7) was used initially, then a 10-
locus VNTR panel was used (Table 1) (8). Spoligotyping 
was as described by Kamerbeek (9). RD analysis was con-
ducted by the method of Brosch et al. (10) for RD1, RD4, 
RD9, RD10, RD12, RDpan, RD17, N-RD17, and N-RD25. 
This study was reviewed and approved by the Clinical Re-
search Ethics Committee of the Cork Teaching Hospitals 
(Ref ECM 3).
Spoligotype signatures were recorded as binary num-
bers (1 and 0 denoting presence and absence of oligonu-
cleotide spacer, respectively). Signatures were matched 
against the M. bovis spoligotype database (www.mbovis.
org) and the global spoligotype database, SpolDB4. Un-
matched spoligotypes were sent to the M. bovis spoligotype 
database curator for an authoritative name assignment (SB 
number). The discriminatory power of VNTR and spoligo-
typing was calculated by using the Hunter Gaston Discrim-
inatory Index. Two or more spoligotype or VNTR patterns 
with 100% identity were considered a cluster. 
Eight spoligotypes (Table 2) were identifi ed among 11 
isolates. Two clusters were identifi ed: 3 strains of SB0140 
(ST683) and 2 strains corresponding to SB0139 (ST680) 
(Table 2). SB0140 (also known as spoligotype A1 or ST1), 
is the most common spoligotype in animals in Ireland and 
the United Kingdom (1,11) (Table 2). SB0139 was previ-
ously detected as an isolate from a cow in Northern Ireland 
in 2000 (SpolDB4; R. Skuce, pers. comm.). Other spoligo-
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types we identifi ed that had been previously reported in iso-
lates from animals in Ireland were SB0130 (ST691), also 
described as D1 or ST7; SB0142 (ST679), also described 
as A2 or ST2; and SB1047 (not found in SpolDB4). Three 
strains were not found in either of the databases. These 
strains were assigned spoligotypes SB1185, SB1186, 
and SB1187 through the M. bovis spoligotype database. 
SB1186 and SB1187 differed from the ubiquitous SB140 
by absence of spacer 35 and spacers 35 and 37, respec-
tively. Previously reported SB0139, SB0142, and SB1047 
differed from SB0140 by absence of spacers 33, 33–34, and 
35–36, respectively. SB1185 differed from the established 
animal strain SB0130 by the absence of spacers 20–21. 
Six-locus VNTR (ETR-A–ETR-F) showed little varia-
tion. The predominant profi le (5 strains) was 7-5-5-4*-3-
3.1. All strains except CUH-HB005 had ETR A–F profi les, 
matching spoligotype SB0140 strains isolated from cattle 
in England and Wales (12). A 10-locus expanded panel de-
rived from loci recently described for Irish zoonotic M. bo-
vis strains (8) improved strain discrimination by producing 
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Table 1. Heterogeneity of each MIRU-VNTR locus of Mycobacterium bovis isolates, southwest Ireland, 1998–2006* 
No. tandem repeat copies 
VNTR locus Isolate 0 1 2 3 4 5 6 7 8 9 10 11 HGDI
Allelic 
variants 
1895 QUB1895 0 0 1 2 8 0 0 0 0 0 0 0 0.47 3
2163a QUB11a 0 0 0 2 0 0 0 0 0 0 4 5 0.69 3
2163b QUB11b 0 1 0 2 8 0 0 0 0 0 0 0 0.47 3
2165 ETR-A 0 0 0 0 1 2 0 8 0 0 0 0 0.47 3
2461 ETR-B 0 0 0 1 1 8 0 1 0 0 0 0 0.49 4
2687 MIRU24 0 6 5 0 0 0 0 0 0 0 0 0 0.55 2
2996 MIRU26 0 0 0 1 1 7 2 0 0 0 0 0 0.60 4
3232 QUB3232 1 0 0 0 0 0 0 0 7 1 1 1 0.62 5
3336 QUB3336 0 0 1 6 3 0 0 1 0 0 0 0 0.67 4
4052 QUB26 0 0 2 1 8 0 0 0 0 0 0 0 0.47 3
*MIRU, mycobacterial interspersed repetitive units; VNTR, variable-number tandem repeats; HGDI, Hunter Gaston Discriminatory Index; QUB, Queen’s 
University Belfast; ETR, exact tandem repeat.  
Table 2. Molecular characteristics of strains and clinical and demographic parameters of 11 patients from whom Mycobacterium bovis 
was isolated, southwest Ireland, 1998–2006* 
Patient data 
Study 
no. Spoligotype SpolDB4†
Mbovis. 
org‡
Other 
name§ 
VNTR 
pattern¶ 
Sex/ 
age, y 
Sample 
site 
Sputum 
smear 
HB002 ??????????????????????????????????????????? ST683 SB0140 A1 4-11-4-7-5- 
1-5-8-3-2 
F/81 Sputum + 
HB008 ??????????????????????????????????????????? ST683 SB0140 A1 3-10-4-5-5- 
1-5-8-3-4 
F/86 Sputum – 
HB010 ??????????????????????????????????????????? ST683 SB0140 A1 4-3-4-7-5- 
1-5-8-3-4 
F/33 Sputum + 
HB011 ??????????????????????????????????????????? ST680 SB0139 NA 4-3-4-7-3- 
1-5-8-3-4 
F/29 Sputum + 
HB012 ??????????????????????????????????????????? ST680 SB0139 NA 4-10-4-7-4- 
1-5-8-3-4 
M/62 Sputum + 
HB006 ??????????????????????????????????????????? ND SB1186 NA 4-11-4-5-5- 
2-5-9-4-4 
M/60 Urine NA 
HB007 ??????????????????????????????????????????? ND SB1047 NA 4-10-3-7-7- 
2-4-x-4-2 
F/74 Neck 
abscess
NA 
HB003 ??????????????????????????????????????????? ST679 SB0142 D1 3-11-4-7-5- 
1-6-8-3-4 
M/37 Spinal 
disc 
aspirate
NA 
HB009 ??????????????????????????????????????????? ND SB1187 NA 4-11-4-7-5- 
2-5-10-4-4 
F/80 Sputum + 
HB001 ??????????????????????????????????????????? ST691 SB130 A2 2-11-3-7-5- 
2-3-8-2-3 
M/16 Sputum + 
HB005 ??????????????????????????????????????????? ND SB1185 NA 4-10-1-4-5- 
2-6-11-7-4 
M/68 Testis 
biopsy 
sample 
NA 
*VNTR, variable number tandem repeats; +, smear positive by auramine and Ziehl-Neelsen stains; ?, smear negative by auramine and Ziehl-Neelsen 
stains; NA, not applicable; ND, not described; x, not determined. 
†Spoligotype designation as described in the SpolDB4 database (www.pasteur-guadeloupe.fr/tb). 
‡Spoligotype assignment as described in the Mbovis.org database (www.mbovis.org).  
§Spoligotype assignment (11). 
¶VNTR profile based on a 10-loci scheme for M. bovis strains from Ireland in this order: QUB1895, QUB11a, QUB11b, ETR-A, ETR-B, MIRU 24, MIRU 
26, QUB 3232, QUB 3336, and QUB26 (8).  
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different profi les for every isolate (Table 1). Hence, VNTR 
typing was able to split the clustered spoligotypes into indi-
vidual profi les. Analysis of regions of difference confi rmed 
that none of the strains were derived from M. bovis BCG. 
Conclusions
A recent outbreak report describing sputum-positive 
M. bovis disease transmitted by person-to-person contact 
(6) underlines the need for precise genetic markers of M. 
bovis to aid epidemiologic traceback. We studied strains 
of M. bovis isolated from humans in the Republic of Ire-
land, and we have defi ned an optimal set of markers using 
a combination of spoligotyping and VNTR. We detected a 
group of isolates (Table 2) of spoligotype SB0140, which 
is predominant in animal strains of M. bovis reported from 
the Republic of Ireland (51.8% of isolates) (11) and the 
United Kingdom (1). It forms the single largest group of M. 
bovis strains isolated from humans in the United Kingdom 
(30%) (1). This group was not reported in a recent series 
of M. bovis isolates from humans in Italy (13) or France 
(14). Indeed, none of the spoligotypes in our survey and 
these reports overlap. Predominant strains by spoligotype 
in animals and those infecting humans in the same country 
are known to be linked (1,13,14). We found 3 novel spo-
ligotypes similar to SB0140 in a small group of patients, 
showing that a wider variety of strains infect humans than 
animals, as described in similar studies (1,2,13). 
In our study, 81% of patients infected were >30 years 
of age (Table 2), comparable with fi ndings of a previous 
survey of the southwest Ireland population (5). Primary 
infection of this group is likely to have been several de-
cades before diagnosis, and our isolates probably represent 
reactivation of disease acquired earlier in life, effectively a 
record of past prevalence in animals. Spoligotype SB0140 
strains were isolated from 2 patients who were >80 years of 
age, showing that the current predominance of SB0140 in 
animals (11) is therefore of long duration in Ireland, poten-
tially going back 8 decades. 
Molecular typing by insertion sequence (IS) 6110–
based restriction fragment length polymorphism is inade-
quate for M. bovis because of low copy numbers of IS6110. 
A combination of MIRU-VNTR and spoligotyping gives 
better discrimination (15). Traditional 6-locus VNTR (ETR-
A–ETR-F) has been described for typing of M. tuberculosis 
complex strains (7) including M. bovis (2), but an expanded 
panel with an additional 10 loci applied to our strains greatly 
improved discrimination and enabled individual identifi ca-
tion of each isolate.
Seven of our 11 isolates were from sputum, and 6 were 
detected on direct smear with potential for transmission. A 
VNTR-typing scheme based on the loci established on M. 
bovis isolates from animals (8) would detect M. bovis clus-
ters derived from foodborne outbreaks or horizontal trans-
mission of disease between humans in Ireland. Our study 
provides ways to markedly improve the ability to identify 
and contact-trace future clusters of M. bovis infection in 
humans. 
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